000			01605nam a2200217Ia 4500
003			MX-MdCICY
005			20250625164353.0
040			_cCICY
090			_aB-21321
245	1	0	_aTherapeutic potential of antifungal plant and insect defensins
490	0		_aDrug Discovery Today. 12(21-22), 966-971, 2007, DOI: 10.1016/j.drudis.2007.07.016
520	3		_aTo defend themselves against invading fungal pathogens, plants and insects largely depend on the production of a wide array of antifungal molecules, including antimicrobial peptides such as defensins. Interestingly, plant and insect defensins display antimicrobial activity not only against plant and insect pathogens but also against human fungal pathogens, including Candida spp. and Aspergillus spp. This review focuses on these defensins as novel leads for antifungal therapeutics. Their mode of action, involving interaction with fungus-specific sphingolipids, and heterologous expression, required for cost-effective production, are major assets for development of plant and insect defensins as antifungal leads. Studies evaluating their in vivo antifungal efficacy demonstrate their therapeutic potential. © 2007 Elsevier Ltd. All rights reserved.
700	1	2	_aThevissen K.
700	1	2	_aKristensen H.-H.
700	1	2	_aThomma B.P.H.J.
700	1	2	_aCammue B.P.A.
700	1	2	_aFrançois I.E.J.A.
856	4	0	_uhttps://drive.google.com/file/d/152N1YZPKhQrpCraHG_pKXlDjLn90vEzD/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta @cicy.edu.mx
942			_2Loc _cREF1
008			250602s9999 xx |||||s2 |||| ||und|d
999			_c55386 _d55386